JRCT ID: jRCT2080220972
Registered date:21/01/2010
Long-term Safety and Tolerability of TRI476 (Oxcarbazepine) in Children With Inadequately Controlled Partial Onset Seizures
Basic Information
Recruitment status | completed |
---|---|
Health condition(s) or Problem(s) studied | |
Date of first enrollment | 05/01/2010 |
Target sample size | 170 |
Countries of recruitment | Japan |
Study type | Interventional |
Intervention(s) | investigational material(s) Generic name etc : INN of investigational material : oxcarbazepine Therapeutic category code : 113 Antiepileptics Dosage and Administration for Investigational material : control material(s) Generic name etc : INN of investigational material : - Therapeutic category code : --- Other Dosage and Administration for Investigational material : |
Outcome(s)
Primary Outcome | safety |
---|---|
Secondary Outcome | safety efficacy |
Key inclusion & exclusion criteria
Age minimum | >= 4age old |
---|---|
Age maximum | <= 15age old |
Gender | Both |
Include criteria | |
Exclude criteria |
Related Information
Primary Sponsor | Nobelpharma Co. Ltd. |
---|---|
Secondary Sponsor | |
Source(s) of Monetary Support | |
Secondary ID(s) | NCT01051193,JapicCTI-101005 |
Contact
Public contact | |
Name | |
Address | |
Telephone | +81-3-6670-3800 |
Affiliation | |
Scientific contact | |
Name | |
Address | |
Telephone | +81-3-6670-3800 |
Affiliation |